查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1912823

血栓彈力圖設備市場按產品類型、技術、檢體類型、測試類型、應用和最終用戶分類 - 全球預測 2026-2032 年

Thromboelastography Machine Market by Product Type, Technology, Sample Type, Test Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血栓彈性測量市場價值將達到 5.341 億美元，到 2026 年將成長至 5.7172 億美元，到 2032 年將達到 8.555 億美元，複合年成長率為 6.96%。

關鍵市場統計數據
基準年 2025 5.341億美元
預計年份：2026年 5.7172億美元
預測年份 2032 8.555億美元
複合年成長率 (%) 6.96%

本書為臨床、營運和商業性因素如何重塑血栓彈力圖及其在醫療保健領域的應用提供了權威指導。

血栓彈力圖設備已從純粹的研究工具發展成為支持手術全期和重症監護決策的關鍵臨床資產。本執行摘要探討了影響該設備在急診、輸血醫學和研究實驗室應用的核心進展、實際操作情況和策略轉折點。本文旨在為希望了解檢測法系統中臨床效用、技術和商業化如何交織的管理者、臨床醫生和投資者提供簡潔明了、基於證據的指導。

小型化、演算法分析和工作流程整合如何融合，進而改變床邊凝血評估和臨床決策路徑

血栓彈力圖領域正經歷著一場變革性的轉變，其驅動力包括設備小型化、數據整合以及臨床工作流程的改進。便攜性和床邊檢測是設備設計的核心，使臨床醫生能夠在急診室、手術室和加護病房快速獲得可操作的凝血功能分析結果。同時，製造商正優先開發基於試劑盒的檢測方法和封閉式工作流程，以減少檢測結果的變異性並簡化操作人員的培訓。這些措施最終將提升臨床醫師的信心，並加速血栓彈力圖在醫療機構中的普及應用。

2025年，隨著關稅環境的累積，策略供應鏈重組和採購應對措施將重塑成本、採購和產品發布計畫。

美國2025年實施的累積關稅和貿易措施，為依賴跨國供應鏈採購關鍵零件、耗材和成品設備的企業帶來了重大挑戰。關稅壓力迫使企業迫切需要重新評估籌資策略、重新談判供應商契約，並評估成本上漲在多大程度上可以被企業吸收並轉嫁給醫療保健採購方。高度依賴進口電子模組、感測器和一次性耗材的製造商受到的影響尤其嚴重，需要在採購、定價和生產計畫方面採取策略性應對措施。

深度細分分析揭示了產品形態、分析平台、臨床應用和終端用戶環境如何相互作用，從而影響設備的選擇和採用。

血栓彈力圖市場的細分揭示了不同的價值提案，這些主張與臨床工作流程和採購趨勢密切相關。可攜式和固定式設備之間的差異會影響設備的部署地點。可攜式設備，包括桌上型和真正的手持式設備，可在手術全期和急診環境中實現快速就地檢驗，而固定式系統則定位為核心檢查室和高通量診斷中心的核心設備。在手持式產品系列中，電池供電型號和插電式設備之間的權衡會影響其在電源不穩定或移動性至關重要的環境中的應用。

美洲、歐洲、中東和非洲以及亞太地區的不同區域趨勢如何影響需求推動要素、採購政策和市場進入要務？

區域趨勢影響著醫療設備製造商和醫療採購負責人的需求模式和策略重點。在美洲，集中式醫院系統、高頻率的手術全期手術以及完善的輸血管理方案是推動醫療器材普及的主要因素。這些因素有利於那些能夠無縫融入現有臨床路徑、提供明確的臨床效用證據並擁有強大的服務網路以支持高使用率的醫療器材。該地區的報銷機制和醫院採購流程往往獎勵那些能夠顯著減少血液製品使用量並顯著改善患者預後的醫療器材。

競爭行為和策略重點驅動市場領導地位，而產品模組化、耗材經濟性和臨床證據也驅動市場領導地位。

血栓彈力圖領域的競爭動態取決於產品差異化、耗材經濟性以及透過同行評審證據和真實世界檢驗來證明其臨床效用的能力。主要企業正投資於支援多種檢測、增強連接性和簡化耗材形式的模組化平台，以創造持續的收入來源。這種對主導經濟性的關注意味著，包括保固、校準和託管服務在內的售後策略與初始銷售同等重要。

為製造商和醫療系統領導者提供可操作的策略重點，以推動臨床應用，同時保護利潤率和供應鏈彈性。

產業領導者應採取果斷措施，在滿足臨床需求和採購限制的同時，保護利潤並加速產品推廣。首先，透過供應鏈地域多角化，降低關稅風險並縮短前置作業時間。盡可能結合多源採購和本地組裝，以保障交貨時間，並使機構買家能夠更準確地預測價格。其次，透過盒式檢測、照護現場品管和整合決策支持，優先考慮臨床第一線操作的便利性，從而縮短培訓週期，並將設備整合到手術全期和重症監護工作流程中。

一項透明的混合方法調查方法，結合了臨床醫生訪談、設備技術分析、文獻綜述和情境檢驗，確保了研究結果的可操作性。

本分析的調查方法結合了質性研究和嚴謹的二手檢驗，以確保得出平衡且切實可行的見解。一級資訊來源包括對手術全期和重症監護醫生、醫院和診斷中心的採購經理以及醫療設備製造商的產品和供應鏈主管進行的結構化訪談。這些訪談主要圍繞著營運流程、採購決策標準以及對近期關稅和供應鏈中斷的因應措施。

本文簡明扼要地總結了各項策略要務，闡述了臨床效用、供應鏈韌性和實證實踐如何結合，從而形成成功的市場策略。

總之，血栓彈力圖市場環境正處於快速臨床應用和營運挑戰並存的階段，需要周全的策略應對。便攜性、自動化和數位分析技術的進步使臨床醫生能夠在床邊更快、更自信地做出決策。同時，按產品類型、技術、應用和最終用戶分類的市場細分也決定了不同的應用路徑。此外，關稅相關的壓力和供應鏈的複雜性凸顯了採購韌性、靈活的商業模式以及與機構負責人清晰溝通的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 血栓彈力圖設備市場（依產品類型分類）

  • 可攜式設備
    • 桌面設備
    • 手持裝置
      • 電池供電
      • 插入式
  • 固定設備

9. 按技術分類的血栓彈力圖設備市場

  • 旋轉血栓彈力圖
    • Delta系列
    • Sigma系列
  • Sonoclot 分析
  • 血栓彈力圖
    • 5000系列
    • 系列 6

第10章：血栓彈力圖設備市場（檢體類型分類）

  • 去除血小板的血漿
  • 富血小板血漿
  • 全血

第11章 血栓彈力圖設備市場（依測試類型分類）

  • 血液凝固檢驗
  • 纖維蛋白溶解試驗
  • 血小板功能檢查

第12章 血栓彈力圖設備市場（依應用領域分類）

  • 急診室
  • 加護病房
    • 成人加護病房
    • 兒童加護病房
  • 研究所
  • 外科手術
    • 心臟外科手術
    • 肝臟移植
    • 整形外科手術

第13章 血栓彈力圖設備市場（依最終用戶分類）

  • 門診手術中心
  • 血庫
  • 診斷中心
    • 醫院檢查室
    • 獨立檢驗機構
  • 醫院
    • 私立醫院
    • 公立醫院

第14章 血栓彈力圖設備市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 血栓彈力圖設備市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國血栓彈力圖設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國血栓彈力圖設備市場

第18章：中國血栓彈力圖設備市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Chongqing Jinjiu Biotech Co., Ltd.
  • Diagnostica Stago SAS
  • F. Hoffmann-La Roche Ltd.
  • Framar Hemologix Srl
  • Haemonetics Corporation
  • Lepu Medical Technology Co., Ltd.
  • Medcaptain Medical Technology Co., Ltd.
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Render Biotech Co., Ltd.
  • Siemens Healthineers AG
  • Sienco, Inc.
  • Sysmex Corporation
  • Werfen, SA
Product Code: MRR-AE420CB13ABE

The Thromboelastography Machine Market was valued at USD 534.10 million in 2025 and is projected to grow to USD 571.72 million in 2026, with a CAGR of 6.96%, reaching USD 855.50 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 534.10 million
Estimated Year [2026] USD 571.72 million
Forecast Year [2032] USD 855.50 million
CAGR (%) 6.96%

An authoritative orientation to the clinical, operational, and commercial drivers reshaping thromboelastography devices and their adoption across healthcare settings

Thromboelastography instruments have evolved from purely research tools into mission-critical clinical assets that inform perioperative and critical care decision-making. This executive summary introduces the core advancements, operational realities, and strategic inflection points shaping device adoption across acute care, transfusion medicine, and research laboratories. The purpose here is to deliver a concise, evidence-driven orientation for executives, clinicians, and investors seeking to understand where clinical utility, technology, and commercialization intersect within the thromboelastography ecosystem.

Recent clinical practice patterns increasingly emphasize rapid, integrated coagulation profiling at the point of care to guide transfusion decisions, anticoagulation management, and perioperative haemostasis. As a result, both device form factors and analytic capabilities have adapted to meet demand for faster turnarounds, more robust clinical validation, and seamless workflow integration. In parallel, regulatory and procurement stakeholders are reassessing purchasing criteria, favoring systems that combine reliability with cost-efficiency and predictable consumable economics.

This introduction frames subsequent sections that analyze technological shifts, tariff-related supply chain impacts, segmentation-level insights, regional dynamics, competitive behaviors, and recommended strategic actions. Throughout, the emphasis is on translating clinical needs into commercial strategy while maintaining methodological transparency and practical recommendations for immediate implementation.

How miniaturization, algorithmic analytics, and workflow integration are converging to transform bedside coagulation assessment and clinical decision pathways

The thromboelastography landscape is experiencing transformative shifts driven by miniaturization, data integration, and changing clinical workflows. Portability and bedside testing have become central to device design, enabling clinicians to obtain actionable coagulation profiles in the emergency department, operating room, and intensive care unit with reduced turnaround time. Concurrently, manufacturers are prioritizing cartridge-based assays and closed workflows that lower variability and simplify operator training, which in turn accelerates clinician confidence and institutional uptake.

Digital transformation is another cornerstone of change. Devices now commonly include connectivity for electronic health record integration, cloud-based analytics, and remote monitoring that support quality assurance and longitudinal patient management. Emerging analytic tools apply algorithmic interpretation to thromboelastography traces, helping to standardize recommendations for transfusion and anticoagulation. These enhancements are not purely technological; they underpin a shift toward evidence-driven, protocolized care pathways in which coagulation testing informs immediate therapeutic choices.

Clinical practice trends also reflect broader healthcare priorities: blood conservation initiatives, constrained budgets for transfusion products, and increased demand for personalized perioperative care. These pressures incentivize solutions that demonstrate clear workflow advantages, reproducibility, and cost predictability through consumable and service models. Finally, industry-level consolidation, academic partnerships for clinical validation, and targeted regulatory strategies are accelerating product refinement and commercial scale-up, reinforcing a virtuous cycle of innovation and clinical adoption.

Strategic supply chain realignment and procurement responses to the cumulative tariff landscape that reshaped cost, sourcing, and product launch planning in 2025

The imposition of cumulative tariffs and trade measures in the United States during 2025 has introduced material considerations for companies that rely on cross-border supply chains for critical components, consumables, and finished instruments. Tariff pressures have amplified the imperative to reassess sourcing strategies, renegotiate supplier contracts, and evaluate the extent to which cost increases can be absorbed versus passed on to institutional purchasers. Manufacturers with significant exposure to imported electronic modules, sensors, or single-use cartridges are particularly affected, prompting strategic responses across procurement, pricing, and production planning.

In practical terms, the tariff environment has lengthened lead times and elevated procurement risk for device makers and hospital buyers alike. Some firms have accelerated initiatives to qualify alternative suppliers in tariff-exempt jurisdictions or to regionalize assembly operations to mitigate duty impacts. Others have restructured pricing models-blending capital equipment discounts with higher consumable margins or emphasizing service contracts that create recurring revenue less susceptible to tariff volatility. These adaptations often require additional clinical and regulatory validation, which can lead to temporary delays in new product introductions.

From the vantage point of health systems, tariff-driven cost increases place additional scrutiny on total cost of ownership. Hospitals and diagnostic centers are increasingly seeking transparent cost modeling that separates device acquisition from recurring consumable and service expenses. As a result, procurement decisions are shifting toward systems that demonstrate resilience to supply chain shocks, longer service lifecycles, and clear migratory paths for software and analytic upgrades. For companies, proactive communication about mitigation strategies, inventory buffers, and localization plans has become integral to maintaining commercial credibility with large institutional buyers.

Deep segmentation insights showing how product form factors, analytic platforms, clinical applications, and end-user contexts together drive device selection and adoption

Segmentation in the thromboelastography space reveals differentiated value propositions that intersect with clinical workflows and purchasing preferences. Product type distinctions between portable machines and stationary machines influence where devices are deployed: portable machines, which encompass benchtop devices and truly handheld formats, enable rapid point-of-care testing for perioperative and emergency settings, while stationary systems remain central to core laboratories and high-throughput diagnostic centers. Within handheld offerings, the trade-offs between battery-operated models and plug-in devices inform adoption in settings with variable access to reliable power or where mobility is paramount.

Technology-based segmentation highlights competing analytic philosophies and product families. Rotational thromboelastometry platforms, including devices in delta-style and sigma-style series, emphasize rotational shear mechanics and established parameter sets that appeal to transfusion medicine programs. Sonoclot analysis retains a niche for laboratories valuing viscoelastic clot detection through acoustic profiling, whereas thromboelastography systems with Series 5000 and Series 6s configurations deliver legacy workflows and incremental enhancements tailored to perioperative clinicians. Each technology presents distinct assay menus, user interfaces, and integration pathways that map to different clinical protocols.

Application-driven segmentation illuminates where clinical demand is most concentrated. Emergency departments and surgery suites require rapid, actionable results, while research laboratories value extensible platforms for method development. Intensive care units split into distinct adult and pediatric streams, each with specific assay sensitivities and blood volume considerations. Surgical sub-specialties such as cardiac surgery, liver transplantation, and orthopedic surgery have particular coagulation management needs that shape device selection and clinical guidelines.

End-user categories-ambulatory surgery centers, blood banks, diagnostic centers, and hospitals-define procurement behavior and service expectations. Diagnostic centers differentiate into hospital-based laboratories and independent laboratories, each with different throughput and reimbursement contexts, while hospitals stratify across private and public institutions that vary in capital cycles and formularies. Sample type segmentation across platelet poor plasma, platelet rich plasma, and whole blood affects assay design, pre-analytical workflows, and the clinical interpretability of results. Finally, test type segmentation encompassing coagulation testing, fibrinolysis testing, and platelet function testing dictates both consumable design and the training requirements for clinical staff. Together, these segmentation layers create a complex matrix of clinical needs, economic constraints, and operational requirements that should guide product roadmaps and commercialization strategies.

How distinct regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific define demand drivers, procurement preferences, and market entry imperatives

Regional dynamics shape both demand patterns and strategic priorities for device makers and institutional buyers. In the Americas, adoption is driven by concentrated hospital systems, high rates of perioperative procedures, and established transfusion management programs. These factors favor devices that integrate seamlessly into existing clinical pathways, offer clear evidence of clinical utility, and provide robust service networks to support high-volume use. Reimbursement frameworks and hospital procurement processes in this region tend to reward demonstrable reductions in blood product utilization and measurable improvements in patient outcomes.

Europe, the Middle East & Africa (EMEA) presents a diverse landscape in which regulatory harmonization and national blood management policies exert strong influence. Countries with centralized procurement models and national clinical guidelines often prioritize devices that align with standardized protocols and that can be validated across multiple centers. In markets with constrained healthcare budgets, emphasis is placed on total cost of ownership and the ability to scale training efficiently. Meanwhile, pockets of advanced academic research and specialized surgical programs create demand for high-performance laboratory-class instruments and integrated analytics.

Asia-Pacific exhibits rapid adoption driven by expanding hospital infrastructure, increasing surgical volumes, and growing emphasis on perioperative safety. Local manufacturing capacity and regional supply chains are becoming more important, reducing lead times and enabling competitive pricing. In several markets, rising clinical research activity and collaborations between device makers and academic centers are accelerating evidence generation and clinician familiarity. Across all regions, differences in clinical practice patterns, procurement cycles, and regulatory requirements necessitate tailored market approaches that balance global platform consistency with localized service, training, and pricing models.

Competitive behaviors and strategic priorities revealing how product modularity, consumable economics, and clinical evidence are determining market leadership

Competitive dynamics within the thromboelastography domain are defined by product differentiation, consumable economics, and the ability to demonstrate clinical utility through peer-reviewed evidence and real-world validation. Leading organizations are investing in modular platforms that support multiple assays, enhanced connectivity, and streamlined consumable formats to create recurring revenue streams. This focus on consumable-driven economics means that aftermarket strategy-including warranty, calibration, and managed service offerings-has become as important as the initial sale.

Strategic partnerships between device manufacturers and academic or clinical centers are accelerating the generation of high-quality evidence and real-world data that support guideline inclusion and institutional adoption. Companies that prioritize rigorous multi-center studies and publish outcomes data are better positioned to influence procurement committees and clinical leaders. Additionally, firms that develop comprehensive training programs and remote support services reduce operator variability and improve clinical confidence, making their products more attractive to large hospital systems and diagnostic chains.

Mergers, acquisitions, and licensing agreements are reshaping competitive positioning as firms seek to acquire complementary technologies, secure consumable manufacturing capacity, or expand geographic reach. Those that invest early in digital analytics and cloud-enabled quality assurance are creating additional differentiation by offering decision-support tools and metrics that quantify device impact. For new entrants, the path to scale often requires a clear focus on niche clinical segments where improved outcomes can be most readily demonstrated and then leveraged into broader adoption.

Actionable strategic priorities for manufacturers and health system leaders to advance clinical adoption while protecting margins and supply chain resilience

Industry leaders should take decisive steps to protect margins and accelerate adoption while remaining responsive to clinical needs and procurement constraints. First, diversify and regionalize supply chains to reduce tariff exposure and minimize lead times, combining multi-sourcing with localized assembly where feasible. This will protect delivery schedules and make pricing more predictable for institutional buyers. Second, prioritize point-of-care usability through cartridgeized assays, automated QC, and integrated decision-support to shorten training curves and embed devices within perioperative and critical care workflows.

Third, invest in clinical evidence generation that targets high-impact surgical subspecialties and bleeding management protocols. Multi-center prospective studies and real-world data partnerships with transfusion services will improve guideline uptake and procurement justification. Fourth, adopt flexible commercial models that balance capital and recurring revenue, including subscription services, managed consumable programs, and outcome-linked pricing where appropriate. Fifth, accelerate digital integration by ensuring secure EHR connectivity, cloud analytics for trend monitoring, and remote service capabilities that reduce downtime and support compliance.

Finally, enhance customer success programs with targeted training, competency certification, and rapid-response technical support. These measures decrease user variability, reduce the likelihood of adverse events, and increase the lifetime value of installed systems. By aligning product design, go-to-market strategies, and evidence generation with real-world clinical priorities, companies can achieve durable differentiation and sustainable growth.

A transparent mixed-methods research approach combining clinician interviews, device technical analysis, literature synthesis, and scenario validation to ensure actionable findings

The research methodology underpinning this analysis combined primary qualitative inquiry with rigorous secondary-source validation to ensure balanced and actionable findings. Primary inputs included structured interviews with clinicians in perioperative and critical care specialties, procurement leaders at hospitals and diagnostic centers, and product and supply chain executives within device manufacturing firms. These conversations focused on operational workflows, purchasing decision criteria, and reactions to recent tariff and supply chain disruptions.

Secondary research encompassed peer-reviewed clinical literature on viscoelastic testing modalities, regulatory filings and guidance documents, device technical specifications, and publicly available clinical guidelines related to blood management and transfusion. Data triangulation was applied to reconcile divergent perspectives and to validate recurring themes such as the demand for point-of-care testing and the economic implications of consumable-driven business models. Scenario analysis addressed sensitivity to tariff shocks, supply chain interruptions, and regulatory timeframes for new product clearances.

Throughout the process, findings were subjected to internal expert review by clinicians and industry analysts to test causality and practical relevance. Limitations include inherent variability in clinical practice across institutions and evolving regulatory decisions that can shift timelines for product introductions. Nevertheless, the methodology emphasizes transparency, reproducibility, and the use of multiple evidence streams to support the strategic recommendations and segmentation insights presented in this report.

A concise synthesis of strategic imperatives showing how clinical utility, supply chain resilience, and evidence generation combine to shape successful market approaches

In conclusion, the thromboelastography landscape is poised between rapid clinical adoption and operational challenges that require deliberate strategic responses. Advancements in portability, automation, and digital analytics are enabling clinicians to make faster, more confident decisions at the bedside, while segmentation across product types, technologies, applications, and end users defines distinct routes to adoption. At the same time, tariff-related pressures and supply chain complexities highlight the importance of sourcing resilience, flexible commercial models, and clear communication with institutional purchasers.

To succeed, companies must align product design with real-world clinical workflows, demonstrate impact through robust evidence, and structure pricing and service models that address total cost of ownership concerns. Regional strategies should be tailored to the regulatory and procurement realities of the Americas, EMEA, and Asia-Pacific, recognizing that localized manufacturing and strong service networks can materially influence adoption rates. For health systems, the priority is to select platforms offering reproducible results, streamlined workflows, and responsive support to ensure consistent clinical outcomes.

The recommendations and insights presented here are intended to guide executive decision-making and operational planning, enabling stakeholders to convert emerging opportunities into measurable improvements in patient care and organizational performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Thromboelastography Machine Market, by Product Type

  • 8.1. Portable Machines
    • 8.1.1. Benchtop Devices
    • 8.1.2. Handheld Devices
      • 8.1.2.1. Battery Operated
      • 8.1.2.2. Plug In
  • 8.2. Stationary Machines

9. Thromboelastography Machine Market, by Technology

  • 9.1. Rotational Thromboelastometry
    • 9.1.1. Delta Series
    • 9.1.2. Sigma Series
  • 9.2. Sonoclot Analysis
  • 9.3. Thromboelastography
    • 9.3.1. Series 5000
    • 9.3.2. Series 6s

10. Thromboelastography Machine Market, by Sample Type

  • 10.1. Platelet Poor Plasma
  • 10.2. Platelet Rich Plasma
  • 10.3. Whole Blood

11. Thromboelastography Machine Market, by Test Type

  • 11.1. Coagulation Testing
  • 11.2. Fibrinolysis Testing
  • 11.3. Platelet Function Testing

12. Thromboelastography Machine Market, by Application

  • 12.1. Emergency Department
  • 12.2. Intensive Care Unit
    • 12.2.1. Adult Icu
    • 12.2.2. Pediatric Icu
  • 12.3. Research Laboratories
  • 12.4. Surgery
    • 12.4.1. Cardiac Surgery
    • 12.4.2. Liver Transplantation
    • 12.4.3. Orthopedic Surgery

13. Thromboelastography Machine Market, by End User

  • 13.1. Ambulatory Surgery Centers
  • 13.2. Blood Banks
  • 13.3. Diagnostic Centers
    • 13.3.1. Hospital Based Laboratories
    • 13.3.2. Independent Laboratories
  • 13.4. Hospitals
    • 13.4.1. Private Hospitals
    • 13.4.2. Public Hospitals

14. Thromboelastography Machine Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Thromboelastography Machine Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Thromboelastography Machine Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Thromboelastography Machine Market

18. China Thromboelastography Machine Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Bio-Rad Laboratories, Inc.
  • 19.7. Chongqing Jinjiu Biotech Co., Ltd.
  • 19.8. Diagnostica Stago S.A.S.
  • 19.9. F. Hoffmann-La Roche Ltd.
  • 19.10. Framar Hemologix S.r.l.
  • 19.11. Haemonetics Corporation
  • 19.12. Lepu Medical Technology Co., Ltd.
  • 19.13. Medcaptain Medical Technology Co., Ltd.
  • 19.14. Mindray Bio-Medical Electronics Co., Ltd.
  • 19.15. Render Biotech Co., Ltd.
  • 19.16. Siemens Healthineers AG
  • 19.17. Sienco, Inc.
  • 19.18. Sysmex Corporation
  • 19.19. Werfen, S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES THROMBOELASTOGRAPHY MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BENCHTOP DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BENCHTOP DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BENCHTOP DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BATTERY OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BATTERY OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BATTERY OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLUG IN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLUG IN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLUG IN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY STATIONARY MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY STATIONARY MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY STATIONARY MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DELTA SERIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DELTA SERIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DELTA SERIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SIGMA SERIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SIGMA SERIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SIGMA SERIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SONOCLOT ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SONOCLOT ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SONOCLOT ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SERIES 5000, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SERIES 5000, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SERIES 5000, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SERIES 6S, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SERIES 6S, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SERIES 6S, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLATELET POOR PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLATELET POOR PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLATELET POOR PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLATELET RICH PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLATELET RICH PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLATELET RICH PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COAGULATION TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COAGULATION TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY FIBRINOLYSIS TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY FIBRINOLYSIS TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY FIBRINOLYSIS TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLATELET FUNCTION TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLATELET FUNCTION TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PLATELET FUNCTION TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY EMERGENCY DEPARTMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY EMERGENCY DEPARTMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY EMERGENCY DEPARTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ADULT ICU, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ADULT ICU, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ADULT ICU, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PEDIATRIC ICU, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PEDIATRIC ICU, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PEDIATRIC ICU, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY LIVER TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY LIVER TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 261. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 264. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 265. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 267. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 268. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 272. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 273. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 275. GCC THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE MACHINES, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HANDHELD DEVICES, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY THROMBOELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY INTENSIVE CARE UNIT, 2018-2032 (USD MILLION)

TABLE 30